Who Paid My Doc
Olinvyk
Drug Pain Management
NDC 71308-011-10
General payments
$547,551
Research payments
$1,028,878
Through program year 2024, $547,551 in general payments and $1,028,878 in research payments were reported against Olinvyk (Pain Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $56,401 | 50 |
| 2023 | General | $107,226 | 571 |
| 2023 | Research | $244,004 | 7 |
| 2022 | General | $239,968 | 894 |
| 2022 | Research | $758,249 | 12 |
| 2021 | General | $143,955 | 1,724 |
| 2021 | Research | $26,625 | 6 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2024.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
3,239 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.